Position in ROIV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$36,244,314
+$8,391,051 QoQ
Shares Held
1,024,140
+1.9% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#67
of 494 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. ROIV ranks #15 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in ROIV
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,244,314 | 1,024,140 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $27,853,263 | 1,005,533 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $20,424,516 | 941,222 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $14,433,005 | 953,933 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $10,958,214 | 972,335 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $9,773,567 | 968,639 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $11,646,859 | 984,519 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $11,652,606 | 1,009,758 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $12,212,281 | 1,155,372 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $13,435,727 | 1,274,737 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $407,390 | 36,277 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $487,114 | 41,705 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $288,277 | 28,599 | Shares | Defined | 2023-08-07 | |
| No filing history on record for this holder in this stock. | ||||||